Clinical Trial Update: This is an Open-label, Multi-center, Extension Study Designed to Evaluate the Longer Term Safety, Tolerability and Effectiveness of Lurasidone, Flexibly Dosed, Adjunctive to Lithium or Divalproex for the Treatment of Subjects With Bipolar I Disorder Who Have Participated in Study D1050296 [Phase 3]

View source ↗

Summary

Open-label extension study assessing long-term safety, tolerability, and effectiveness of lurasidone added to lithium or divalproex in adults with Bipolar I Dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Latuda (lurasidone)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2016-08-22